Homeschooling for researchers-to-be
Corona lockdown has forced Ullern students to study from home via digital classes.
Research on gene-edited embryos allowed
Important cancer research into gene-editing human embryos will now be possible in Norway
New member: Adjutec Pharma
Meet our new member Adjutec Pharma, a company with new technology against multi-drug resistant bacteria.
Helsenæringens verdi 2020
Helsenæringen er en dobbel mulighet for Norge.
Norwegian cancer drug in COVID 19-programme
Bemcentinib from the Norwegian biotech BerGenBio will be tested on COVID-19 patients.
Artificial intelligence in the fight against COVID-19
Adapting cancer-fighting artificial intelligence technology to combat COVID-19.
